This accumulation could elevate their risk of developing late-onset amyloid-related disorders, such as Alzheimer’s disease.

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

Prolonged rapid eye movement (REM) sleep latency was linked with Alzheimer's disease biomarkers, cross-sectional data showed.

Researchers have demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid ...

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

With this approval, patients who receive the anti-amyloid drug biweekly for 18 months can then consider switching to a monthly dosing regimen.

Researchers demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid later in life, potentially predisposing them to late-onset brain amyloid disorders, ...

The technology – called Antibody Transport Vehicle (ATV): Amyloid beta – can be used to help amyloid-targeting drugs cross the blood brain barrier (BBB) more effectively, say the partners.

CROSS SECTIONS: Dissecting the contentious and the controversial — with science at the core. Recent approvals by the Food and Drug Administration have focused on medications that shrink the sticky ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...